US2015284727A1PendingUtilityA1
Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
Est. expiryOct 23, 2032(~6.3 yrs left)· nominal 20-yr term from priority
C12N 9/16C12N 15/85C12N 9/22C12N 15/8509C12Y 301/21C12N 15/102C12N 15/907C12N 15/113C12N 15/8216C12N 15/52C12Q 1/683C12N 2310/531C12N 15/63A61K 48/005C12N 2310/10C12N 2310/20C12N 15/111
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to targeted genome editing in eukaryotic cells or organisms. More particularly, the present invention relates to a composition for cleaving a target DNA in eukaryotic cells or organisms comprising a guide RNA specific for the target DNA and Cas protein-encoding nucleic acid or Cas protein, and use thereof.
Claims
exact text as granted — not AI-modified1 . A composition for cleaving target DNA in eukaryotic cells or organisms comprising a guide RNA specific for target DNA or DNA that encodes the guide RNA, and Cas protein-encoding nucleic acid or Cas protein.
2 . The composition of claim 1 , wherein the target DNA is an endogenous target DNA.
3 . The composition of claim 1 , wherein the guide RNA is a dualRNA comprising a crRNA and a tracrRNA.
4 . The composition of claim 1 , wherein the guide RNA is a single-chain guide RNA (sgRNA).
5 . The composition of claim 4 , wherein the single-chain guide RNA comprises portion of a crRNA and a tracrRNA.
6 . The composition of claim 1 , wherein the guide RNA further comprises one or more additional nucleotides at the 5′ end of the single-chain guide RNA or the crRNA of the dualRNA.
7 . The composition of claim 1 , wherein the guide RNA further comprises 2 additional guanine nucleotides at the 5′ end of the single-chain guide RNA or the crRNA of the dualRNA.
8 . The composition of claim 1 , which induces targeted mutagenesis in eukaryotic cells or organisms.
9 . The composition of claim 1 , for use in the genotyping of a genome in the eukaryotic cells or organisms in vitro.
10 . The composition of claim 1 , wherein the guide RNA and the Cas protein function as a pair, and wherein the pair comprises two guide RNAs which induce two nicks on different strands.
11 . The composition of claim 1 , wherein the guide RNA is in the form of an isolated RNA, or is encoded in a vector, wherein the vector is a viral vector, plasmid vector, or agrobacterium vector.
12 . The composition of claim 1 , comprising a guide RNA specific for the target DNA and Cas9 protein.
13 . The composition of claim 1 , for cleaving the target DNA in eukaryotic cells or organisms ex vivo or in vivo.
14 . The composition of claim 1 , wherein the Cas protein-encoding nucleic acid or the Cas protein is derived from the genus Streptococcus.
15 . The composition of claim 14 , wherein the genus Streptococcus is Streptococcus pyogenes.
16 . The composition of claim 15 , wherein the Cas protein recognizes the NGG trinucleotide.
17 . The composition of claim 1 , wherein the Cas protein is Cas9 protein or variant thereof.
18 . The composition of claim 1 , wherein the Cas protein is linked to a protein transduction domain.
19 . The composition of claim 17 , wherein the variant of Cas9 protein is a mutant form of Cas9 in which the catalytic aspartate residue is changed to any other amino acid.
20 . The composition of claim 19 , wherein the amino acid is an alanine.
21 - 57 . (canceled)Join the waitlist — get patent alerts
Track US2015284727A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.